Inventor
FERLIN WALTER
FR17 patents
⚠️ This page may combine multiple inventors who share the name “FERLIN WALTER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVIMMUNE SA
9 patentsUS8034344B2Oct 11, 2011
Anti-IL-6/IL-6R antibodies and methods of use thereof
NOVIMMUNE SA19 citations92
US7700098B2Apr 20, 2010
Anti-interferon gamma antibodies and methods of use thereof
NOVIMMUNE SA19 citations92
US9682142B2Jun 20, 2017
Anti-interferon gamma antibodies and methods of use thereof
NOVIMMUNE SA9 citations84
US10759862B2Sep 1, 2020
Anti-IL-6/IL-6R antibodies and methods of use thereof
NOVIMMUNE SA3 citations83
US9828430B2Nov 28, 2017
Anti-IL-6/IL-6R antibodies
NOVIMMUNE SA3 citations83
US9234034B2Jan 12, 2016
Methods of treating autoimmune diseases using anti-IL6/IL-6R complex antibodies
NOVIMMUNE SA4 citations83
US10689441B2Jun 23, 2020
Anti—TLR4 antibodies and methods of use thereof
NOVIMMUNE SA4 citations68
US11613582B2Mar 28, 2023
Anti-IL-6/IL-6R antibodies and methods of use thereof
NOVIMMUNE SA0 citations62
US12583922B2Mar 24, 2026
Bispecific antibodies targeting CD47 and PD-L1 and methods of use thereof
NOVIMMUNE SA0 citations44
SWEDISH ORPHAN BIOVITRUM AG
6 patentsUS11236158B2Feb 1, 2022
Methods, compositions and dosing regimens for treating or preventing interferon-gamma related indications
SWEDISH ORPHAN BIOVITRUM AG2 citations69
US11091543B2Aug 17, 2021
Methods, compositions and dosing regimens for treating or preventing interferon-gamma related indications
SWEDISH ORPHAN BIOVITRUM AG3 citations69
US11034760B2Jun 15, 2021
Methods and compositions for diagnosis and treatment of disorders in patients with elevated levels of CXCL9 and other biomarkers
SWEDISH ORPHAN BIOVITRUM AG4 citations69
US12297264B2May 13, 2025
Methods, compositions and dosing regimens for treating or preventing interferon-gamma related indications
SWEDISH ORPHAN BIOVITRUM AG0 citations59
US12275785B2Apr 15, 2025
Methods and compositions for diagnosis and treatment of disorders in patients with elevated levels of CXCL9 and other biomarkers
SWEDISH ORPHAN BIOVITRUM AG0 citations59
US12195530B2Jan 14, 2025
Methods, compositions and dosing regimens for treating or preventing interferon-gamma related indications
SWEDISH ORPHAN BIOVITRUM AG0 citations59